Atomistry » Calcium » PDB 5ik8-5jan » 5j4k
Atomistry »
  Calcium »
    PDB 5ik8-5jan »
      5j4k »

Calcium in PDB 5j4k: Structure of Humanised Rada-Mutant HUMRADA22F in Complex with 1- Indane-6-Carboxylic Acid

Protein crystallography data

The structure of Structure of Humanised Rada-Mutant HUMRADA22F in Complex with 1- Indane-6-Carboxylic Acid, PDB code: 5j4k was solved by G.Fischer, M.Marsh, T.Moschetti, T.Sharpe, D.Scott, M.Morgan, H.Ng, J.Skidmore, A.Venkitaraman, C.Abell, T.L.Blundell, M.Hyvonen, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 50.20 / 1.35
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 40.440, 61.214, 87.742, 90.00, 90.00, 90.00
R / Rfree (%) 12.9 / 16.4

Other elements in 5j4k:

The structure of Structure of Humanised Rada-Mutant HUMRADA22F in Complex with 1- Indane-6-Carboxylic Acid also contains other interesting chemical elements:

Sodium (Na) 2 atoms

Calcium Binding Sites:

The binding sites of Calcium atom in the Structure of Humanised Rada-Mutant HUMRADA22F in Complex with 1- Indane-6-Carboxylic Acid (pdb code 5j4k). This binding sites where shown within 5.0 Angstroms radius around Calcium atom.
In total only one binding site of Calcium was determined in the Structure of Humanised Rada-Mutant HUMRADA22F in Complex with 1- Indane-6-Carboxylic Acid, PDB code: 5j4k:

Calcium binding site 1 out of 1 in 5j4k

Go back to Calcium Binding Sites List in 5j4k
Calcium binding site 1 out of 1 in the Structure of Humanised Rada-Mutant HUMRADA22F in Complex with 1- Indane-6-Carboxylic Acid


Mono view


Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 1 of Structure of Humanised Rada-Mutant HUMRADA22F in Complex with 1- Indane-6-Carboxylic Acid within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Ca403

b:21.8
occ:1.00
H A:THR145 2.5 16.5 0.6
H A:THR145 2.5 16.5 0.5
H A:GLY143 2.6 16.6 1.0
H A:GLN146 2.7 14.8 1.0
O A:HOH624 2.9 34.7 1.0
HG2 A:GLN146 3.0 20.9 1.0
HB A:THR145 3.0 20.1 1.0
HA2 A:GLY143 3.0 17.7 1.0
O A:HOH675 3.1 49.1 1.0
N A:THR145 3.2 13.8 1.0
H A:LYS144 3.2 15.6 0.6
N A:GLY143 3.2 13.8 1.0
C A:GLY143 3.3 13.4 1.0
CA A:GLY143 3.3 14.8 1.0
N A:LYS144 3.3 13.0 0.6
H A:LYS144 3.3 16.6 0.5
N A:LYS144 3.4 13.9 0.5
HA2 A:GLY141 3.5 25.6 1.0
N A:GLN146 3.5 12.4 1.0
HG2 A:LYS144 3.7 23.4 0.5
H A:GLY141 3.7 26.8 1.0
HG2 A:LYS144 3.8 23.6 0.6
CB A:THR145 3.8 16.8 1.0
CG A:GLN146 3.9 17.4 1.0
CA A:THR145 3.9 13.6 1.0
O A:GLY143 3.9 13.5 1.0
HB2 A:GLN146 4.0 16.8 1.0
CA A:GLY141 4.1 21.4 1.0
C A:LYS144 4.1 13.4 0.5
C A:LYS144 4.1 13.4 0.6
C A:GLY141 4.2 17.8 1.0
C A:THR145 4.2 13.9 1.0
HG3 A:GLN146 4.2 20.9 1.0
HE21 A:GLN146 4.2 34.4 1.0
HG3 A:LYS144 4.2 23.6 0.6
CA A:LYS144 4.2 13.5 0.6
N A:GLY141 4.3 22.3 1.0
HA3 A:GLY143 4.3 17.7 1.0
CA A:LYS144 4.3 14.1 0.5
N A:SER142 4.3 15.8 1.0
CB A:GLN146 4.3 14.0 1.0
H A:SER142 4.3 18.9 1.0
HG3 A:LYS144 4.4 23.4 0.5
CG A:LYS144 4.4 19.6 0.6
OG1 A:THR145 4.4 22.1 1.0
CG A:LYS144 4.4 19.5 0.5
C A:SER142 4.5 13.2 1.0
HZ2 A:LYS144 4.5 27.4 0.6
CA A:GLN146 4.5 12.5 1.0
O A:GLY141 4.6 19.3 1.0
HA A:THR145 4.8 16.3 1.0
O A:HOH601 4.8 26.9 1.0
HD13 A:ILE342 4.8 26.2 1.0
NE2 A:GLN146 4.8 28.7 1.0
CD A:GLN146 4.9 21.7 1.0
HD11 A:ILE342 4.9 26.2 1.0
CB A:LYS144 4.9 17.5 0.6
H A:LEU147 4.9 13.2 1.0
HG22 A:THR145 5.0 21.4 1.0
CG2 A:THR145 5.0 17.9 1.0
HA3 A:GLY141 5.0 25.6 1.0
CB A:LYS144 5.0 16.8 0.5
HG A:SER142 5.0 22.2 1.0

Reference:

T.Moschetti, T.Sharpe, G.Fischer, M.E.Marsh, H.K.Ng, M.Morgan, D.E.Scott, T.L.Blundell, A.R Venkitaraman, J.Skidmore, C.Abell, M.Hyvonen. Engineering Archeal Surrogate Systems For the Development of Protein-Protein Interaction Inhibitors Against Human RAD51. J.Mol.Biol. V. 428 4589 2016.
ISSN: ESSN 1089-8638
PubMed: 27725183
DOI: 10.1016/J.JMB.2016.10.009
Page generated: Sun Jul 14 20:51:38 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy